liver cirrhosis

Search with Google Search with Bing
Information
Disease name
liver cirrhosis
Disease ID
DOID:5082
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02849132 Active, not recruiting Phase 4 Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients January 2016 December 2025
NCT03721952 Active, not recruiting N/A Facilitating Communication Study April 17, 2019 June 30, 2024
NCT05080465 Active, not recruiting Phase 3 Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis December 2, 2018 December 31, 2025
NCT03731923 Active, not recruiting N/A Abbreviated MRI for HCC Surveillance November 8, 2018 December 31, 2023
NCT02011932 Active, not recruiting Prospective Observational Study of Disease Progression in Chronic Hepatitis C July 2010 July 2030
NCT03446521 Active, not recruiting AGRA Before and After Liver Transplantation July 6, 2018 December 2024
NCT05513651 Active, not recruiting Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT July 1, 2016 December 30, 2030
NCT04283994 Active, not recruiting N/A Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) July 26, 2021 August 1, 2025
NCT03633279 Active, not recruiting Phase 3 Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C June 22, 2018 October 2023
NCT03694600 Active, not recruiting Clinical Trial Multi-analyte Blood Test February 4, 2019 June 30, 2024
NCT05641025 Active, not recruiting Prediction of Multidrug-resistant Bacterial Infection in Patients With Cirrhosis November 16, 2022 January 30, 2023
NCT05756699 Active, not recruiting Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma April 10, 2023 December 31, 2025
NCT00245830 Completed N/A Ischemic Preconditioning of Liver in Cadaver Donors October 2003 March 2007
NCT00273247 Completed Phase 3 Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis June 1998 September 2005
NCT06384443 Completed Proton Pump Inhibitors in Cirrhotic Patients October 1, 2020 March 1, 2024
NCT00287235 Completed N/A Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) September 2000 April 2004
NCT00296244 Completed Phase 4 Steroid Free Immunosuppression in Liver Transplantation February 2006 June 2008
NCT00304551 Completed Phase 3 A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) June 2006 June 2010
NCT00312910 Completed N/A Probiotics for the Prevention of Major Complications of Cirrhosis April 2005 October 2007
NCT00344916 Completed Phase 1 Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
NCT00358878 Completed Phase 3 Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) July 2006 December 2008
NCT00378599 Completed Phase 3 Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) May 2006 July 2009
NCT00469131 Completed Phase 3 Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid September 2003 August 2011
NCT00488917 Completed Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study) June 2007 August 2009
NCT00501384 Completed Phase 2 Satavaptan Dose-Ranging Study in the Prevention of Ascites April 2004 May 2005
NCT00501566 Completed Phase 2 Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites April 2004 January 2005
NCT00501722 Completed Phase 2 Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites April 2004 March 2005
NCT00562783 Completed Phase 2 A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis January 2005 May 2006
NCT00592475 Completed Phase 2 A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients December 2007 November 2008
NCT00628160 Completed Phase 2/Phase 3 Terlipressin in Septic Shock in Cirrhosis October 2006 December 2012
NCT00679692 Completed Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease September 2006 March 2008
NCT00687219 Completed Phase 3 Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) June 2007 October 2010
NCT00689754 Completed N/A Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed January 2008 August 2011
NCT02787772 Completed N/A Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? January 2009 January 2016
NCT02785835 Completed Hepatocellular Carcinoma in HIV-infected Patients May 2014 June 30, 2021
NCT02693847 Completed Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients February 2006 December 2020
NCT02695628 Completed Phase 2 [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer September 13, 2016 October 31, 2018
NCT02702739 Completed Phase 4 Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients January 2015 February 2016
NCT00039871 Completed Phase 3 PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) May 2002 September 2007
NCT00147043 Completed N/A Adult Stem Cell Therapy in Liver Insufficiency January 2005 June 2005
NCT00168961 Completed Phase 4 Enteral Nutrition in Liver Cirrhosis December 2003 June 2007
NCT00212186 Completed N/A Selenium Supplementation of Patients With Cirrhosis October 1998 November 2003
NCT00232427 Completed N/A PiCCO Guided Therapy in Liver Cirrhosis August 2005 August 2007
NCT00243633 Completed N/A Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS) April 2005 August 2007
NCT00245310 Completed Indocyangreen Elimination in Cirrhosis and Acute Liver Failure October 2005 October 2010
NCT02226939 Completed Phase 2 Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C September 2002
NCT02230670 Completed Phase 2 A Study of IDN-6556 in Subjects With Liver Cirrhosis August 2014 January 2016
NCT02230683 Completed Phase 2 A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension August 2014 June 2015
NCT03723317 Completed Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival January 15, 2018 October 15, 2018
NCT02297867 Completed Phase 1 Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis July 13, 2015 March 27, 2018
NCT03590288 Completed Dynamic Monitor of Portacaval Pressure Gradient May 1, 2018 August 31, 2023
NCT03587623 Completed Copeptin Serum Level in Liver Transplant Recipients July 4, 2018 January 31, 2020
NCT02335073 Completed Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis January 2015 June 2016
NCT02335580 Completed Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis December 2014 December 2022
NCT02362178 Completed Phase 2 Thromboelastographic Guide for Blood Products in Cirrhotics February 2011 September 2014
NCT02377141 Completed N/A Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding April 18, 2011 January 31, 2019
NCT03459378 Completed Outcome After TIPS March 23, 2018 May 14, 2020
NCT03438916 Completed MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis April 1, 2017 December 8, 2020
NCT03405909 Completed Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study April 21, 2018 April 6, 2019
NCT03345498 Completed Entecavir for Decompensated HBV Cirrhosis January 1, 2017 December 31, 2018
NCT03342703 Completed Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI August 1, 2018 December 31, 2020
NCT02421848 Completed Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXA January 2012 December 2014
NCT00006166 Completed Phase 3 North American Study for the Treatment of Refractory Ascites (NASTRA) March 1997 October 2001
NCT03337945 Completed N/A In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis April 4, 2018 December 31, 2021
NCT03318380 Completed N/A Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis January 19, 2018 November 3, 2022
NCT02468479 Completed Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis June 2015 December 2016
NCT03263598 Completed Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites May 2016 February 2020
NCT00006398 Completed Phase 3 Prevention of Esophageal Varices by Beta-Adrenergic Blockers August 1993 September 2002
NCT03175731 Completed Phase 4 PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) May 1, 2017 August 30, 2019
NCT02508688 Completed N/A Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax January 2005 June 2015
NCT02996188 Completed Acute Hemodynamic Changes During Paracentesis June 2012 November 2013
NCT02975726 Completed N/A Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites January 2017 February 2019
NCT02957253 Completed N/A Effects on Liver Cirrhotic Patients' by a Nurse-led Clinic November 17, 2016 December 31, 2022
NCT02593799 Completed Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study May 1, 2015 December 31, 2018
NCT02949505 Completed N/A Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation March 1, 2017 August 1, 2018
NCT02917408 Completed Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital September 2016 January 2017
NCT02859610 Completed N/A Microparticles in Cirrhosis and Portal Hypertension January 2014 January 2015
NCT02802228 Completed Phase 2 Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients March 6, 2017 July 17, 2018
NCT02669875 Completed Phase 2 Serelaxin To Lower Portal Pressure October 18, 2017 August 31, 2018
NCT00816127 Completed N/A Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction October 2003 May 2007
NCT00831337 Completed N/A Evaluation of Probiotics in the Treatment of Portal Hypertension April 2007 February 2011
NCT05989789 Completed N/A Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients June 15, 2020 June 30, 2021
NCT00956098 Completed Phase 2 Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis February 2006 February 2007
NCT00965744 Completed Phase 4 A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension January 2006 December 2008
NCT01002261 Completed Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects October 2009 January 2015
NCT01006031 Completed Phase 2/Phase 3 Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 October 2009 December 2011
NCT01013194 Completed Phase 1/Phase 2 Human Fetal Liver Cell Transplantation in Chronic Liver Failure February 2007 July 2011
NCT05786755 Completed Compositional Shift of Gut Microbiome According to the Complications in Patients With Liver Cirrhosis August 15, 2018 July 10, 2021
NCT01045525 Completed Phase 3 Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis January 2010 December 2015
NCT01062750 Completed N/A Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells October 2012 May 2015
NCT01082419 Completed N/A Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity April 2010 April 2013
NCT05674877 Completed Phase 3 Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection December 1, 2022 July 30, 2023
NCT01120925 Completed Phase 1/Phase 2 Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients May 2010 July 2013
NCT01147380 Completed Phase 1 Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation June 2010 December 2014
NCT01150916 Completed N/A B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites June 2010 March 2012
NCT01151475 Completed Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE) August 2010 August 2011
NCT01198704 Completed Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) January 2009 January 2020
NCT01201720 Completed N/A Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure" March 2011 February 2013
NCT01220492 Completed Phase 1/Phase 2 Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis May 2009 April 2016
NCT05387811 Completed International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project July 1, 2022 November 30, 2023
NCT05378451 Completed Totally Extraperitoneal Repair of Groin Hernia in Liver Transplanted Patients May 8, 2022 January 1, 2024
NCT05333510 Completed A Comparative Evaluation of TEG Versus ROTEM for Coagulopathy Correction July 1, 2021 January 8, 2022
NCT01265173 Completed Phase 4 Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC April 2007 June 2018
NCT01271660 Completed Phase 3 A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis July 2011 March 2018
NCT05331872 Completed Phase 1 Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis November 1, 2020 September 30, 2023
NCT05250401 Completed Thyroid Function in Liver Cirrhosis: Is it Affected? May 18, 2021 January 18, 2022
NCT01288794 Completed Phase 4 Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis March 2011 May 2016
NCT06457360 Completed Early Phase 1 Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children November 15, 2023 May 20, 2024
NCT05095181 Completed To Study the Effects of Host Genetic Factors on Liver Cirrhosis March 29, 2021 January 20, 2023
NCT01333228 Completed Phase 1/Phase 2 Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis June 2012 March 2015
NCT05082064 Completed Observational Prospective Study.at the End of the Study the Patients Will be Classified According to PH,Serum Bicarbonate and Serum Sodium Into 6 Groups and Statistical Analysis Will be Performed Using Spss October 8, 2021 January 7, 2023
NCT01342250 Completed Phase 1/Phase 2 Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis October 2010 October 2011
NCT01355107 Completed Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease April 2011 December 2011
NCT01361061 Completed AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver June 2010 November 2015
NCT01369979 Completed Hepatic Sugar Metabolism Measured by PET/CT in Patients and Healthy Subjects May 2011 June 2012
NCT05056584 Completed N/A The Role of the Kidneys and Liver in the Elimination of Glucagon August 1, 2020 March 28, 2023
NCT05013502 Completed Phase 1 Empagliflozin in Diuretic Refractory Ascites November 15, 2021 June 30, 2023
NCT05012501 Completed Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients September 1, 2020 February 28, 2021
NCT05008263 Completed Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis August 1, 2018 January 31, 2020
NCT04987034 Completed Comparing a Direct Versus an Indirect Approach to Measuring the Portalsytemic Pressure Gradients July 27, 2021 September 30, 2023
NCT04874350 Completed Phase 2 A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia November 30, 2021 December 18, 2023
NCT01456286 Completed Phase 2/Phase 3 Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension October 2011 October 2013
NCT01470547 Completed Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry April 2012 December 2017
NCT04850534 Completed Systemic Inflammation in Liver Cirrhosis April 1, 2019 October 30, 2023
NCT01492283 Completed Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes December 2011 July 2014
NCT01494064 Completed Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care February 2011 December 2015
NCT01494220 Completed Validation of the Bispectral Index Monitor During Living Donor Liver Transplantation June 2007 February 2011
NCT01495403 Completed Early Phase 1 Treatment of Muscle Cramps in Patients With Liver Cirrhosis December 2011 April 2015
NCT04842539 Completed N/A Fecal Microbiota Transplantation in Decompensated Cirrhosis August 1, 2018 November 30, 2019
NCT04828369 Completed Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With Shunt October 1, 2020 December 31, 2021
NCT01503749 Completed Phase 1 Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis January 2012 August 2014
NCT01509391 Completed N/A Keyhole Limpet Hemocyanin in Chronic Hepatitis C January 2012 October 2012
NCT04826666 Completed Intraoperative Phlebotomies and Bleeding in Liver Transplantation March 31, 2021 November 4, 2021
NCT01532427 Completed ALFApump System Post Marketing Surveillance Registry June 2012 July 8, 2019
NCT04823780 Completed The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis September 1, 2020 October 20, 2021
NCT04809870 Completed Esophagectomy in Patients With Liver Cirrhosis October 1, 2020 April 10, 2021
NCT04789213 Completed Mortality, Morbidity and Risk Factors of Liver Retransplantation March 10, 2021 May 1, 2021
NCT01598064 Completed N/A Probiotics for Liver Cirrhosis With Portal Hypertension April 2012 August 2013
NCT01607528 Completed N/A Influence of Probiotics on Infections in Cirrhosis July 2012 September 2014
NCT04787276 Completed N/A Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy January 10, 2017 March 15, 2020
NCT01619475 Completed Adult-to-Adult Living Donor Transplant Cohort Study February 2011 August 2014
NCT04782050 Completed N/A Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation September 15, 2021 August 29, 2022
NCT04771104 Completed N/A The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver Cirrhosis January 1, 2017 January 22, 2018
NCT04688034 Completed Phase 1 Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV With Hemophilia. March 15, 2021 December 31, 2022
NCT04668664 Completed Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements April 5, 2021 June 13, 2022
NCT04644055 Completed EUS Share-wave in Patients With Liver Cirrhosis March 1, 2020 April 15, 2023
NCT04553328 Completed N/A Ultrasound-guided Ipsilateral Transverse Abdominis Plane and Ilioinguinal Iliohypogastric Nerve Block. September 1, 2019 June 2, 2020
NCT01735591 Completed N/A Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation November 2012 November 2015
NCT01751191 Completed HVPG for Rebleeding Risk Stratification August 2011 December 2012
NCT01762748 Completed Phase 2 Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant January 2011 December 2012
NCT01767597 Completed N/A Application of HBV Rapid Tests as a Tool for Wide-Use Screening February 2012 January 2013
NCT01769040 Completed Phase 4 Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis November 2012 January 2016
NCT01773538 Completed N/A Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement January 2013 November 2015
NCT01804829 Completed Phase 3 Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. June 2013 June 2016
NCT04494542 Completed N/A Sustained Low Efficiency Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury in Critically Ill Cirrhotics October 16, 2020 May 16, 2023
NCT01850940 Completed Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia January 2013 May 2015
NCT01872793 Completed Validation of BIVA for Nutritional Assessment in Cirrhotic Patients January 2010 September 2016
NCT04494451 Completed N/A Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections. September 15, 2021 November 2, 2022
NCT04397289 Completed Phase 1/Phase 2 Anticoagulation Therapy After Splenectomy in Cirrhosis Patient February 12, 2018 March 31, 2021
NCT04391764 Completed N/A Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis. December 6, 2020 October 31, 2022
NCT01904409 Completed Phase 2 Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis June 2013 July 2015
NCT01905254 Completed N/A Transient Elastography in Autoimmune Hepatitis August 2007 January 2013
NCT01909778 Completed Phase 1 Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis June 2008 October 2008
NCT04329559 Completed COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study March 30, 2020 February 10, 2021
NCT01938820 Completed Phase 4 Optimized Treatment and Regression of HBV-induced Early Cirrhosis June 2013 December 2016
NCT01943318 Completed Boramae Hospital Liver Cirrhosis Patient Cohort Study January 2013 May 2022
NCT01943617 Completed Phase 4 Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis June 2013 December 2016
NCT04281784 Completed N/A Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) April 23, 2020 September 26, 2022
NCT04273750 Completed RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal Syndrome March 5, 2018 February 5, 2020
NCT02019784 Completed Phase 4 Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy January 2015 October 2016
NCT02021253 Completed N/A Influence of Probiotics Administration Before Liver Resection in Liver Disease April 2013 April 12, 2018
NCT02022137 Completed N/A Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy October 2013 March 2016
NCT04173429 Completed Phase 4 Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis January 1, 2017 January 31, 2020
NCT04158986 Completed N/A Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis December 1, 2019 October 1, 2022
NCT02023229 Completed Phase 4 Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis January 2011 May 2013
NCT02024347 Completed A New Screening Strategy for Varices July 2013 June 2016
NCT00006161 Completed Phase 3 Decompression Intervention of Variceal Rebleeding Trial (DIVERT) December 1996 December 2003
NCT02047240 Completed Renal Function Determination in Patients With Liver Cirrhosis April 2013 April 2016
NCT04113317 Completed Phase 3 Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation January 1, 2020 February 28, 2022
NCT02069457 Completed Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis December 2013 June 2015
NCT02073435 Completed A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation October 2010 April 2018
NCT02119988 Completed N/A TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis June 16, 2014 November 20, 2020
NCT03753438 Completed Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) Cirrhotics August 2, 2016 May 31, 2020
NCT02125071 Completed Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation November 2013 September 2015
NCT02134626 Completed Phase 3 Simvastatin Effect on Portal Hypertension August 2010 April 2014
NCT02138253 Completed Phase 2 A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV May 2014 March 9, 2018
NCT02156232 Completed N/A Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy June 15, 2014 March 5, 2021
NCT03748563 Completed N/A Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis January 7, 2021 March 6, 2023
NCT03228095 Enrolling by invitation Volatiles in Breath and Headspace Analysis - Diagnostic Markers July 24, 2017 December 31, 2025
NCT05433948 Enrolling by invitation Diagnosing Minimal Hepatic Encephalopathy December 1, 2019 December 1, 2031
NCT04539717 Enrolling by invitation FAST (Focused Abbreviated Screening Technique)-MRI Study August 17, 2020 December 2025
NCT05971082 Enrolling by invitation Risk Factors for Advanced Fibrosis Among FLD Patients August 24, 2023 December 31, 2025
NCT05431946 Enrolling by invitation Palliative Care for Patients With Liver Cirrhosis August 1, 2023 August 1, 2026
NCT06014320 Not yet recruiting Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease October 1, 2023 October 1, 2024
NCT06076330 Not yet recruiting N/A Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension September 30, 2023 August 31, 2024
NCT05895136 Not yet recruiting Phase 2 A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). March 2024 March 2025
NCT05856721 Not yet recruiting N/A Pattern of Intestinal Parasitic Infection Among Cirrhotic Patients in Sohag University Hospital June 2023 June 2024
NCT05853484 Not yet recruiting N/A Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver Transplantation September 1, 2024 August 1, 2025
NCT05848414 Not yet recruiting Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis February 7, 2024 June 7, 2024
NCT06338215 Not yet recruiting N/A Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality May 1, 2024 June 30, 2029
NCT04711122 Not yet recruiting Prophylactic Antibiotics in Prevention of Spontaneous Bacterial Peritonitis in Compensated Liver Cirrhosis December 1, 2022 April 30, 2023
NCT06091345 Not yet recruiting N/A Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites October 25, 2023 February 27, 2025
NCT06337656 Not yet recruiting N/A Vibration Training Approach in Liver Cirrhosis June 1, 2024 April 1, 2026
NCT06153082 Not yet recruiting N/A Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding. November 25, 2023 December 31, 2024
NCT06047327 Not yet recruiting N/A EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease September 15, 2023 August 31, 2024
NCT05677230 Not yet recruiting N/A To Compare the Safety and Efficacy of Balloon Occluded/Plug Assisted Retrograde Transvenous Obliteration With Endoscopic Variceal Obturation for Primary Prophylaxis of Gastric Varices With Large Spontaneous Shunt January 15, 2023 December 31, 2023
NCT03460795 Not yet recruiting Phase 1/Phase 2 Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease June 1, 2020 September 1, 2025
NCT06153914 Not yet recruiting N/A SALT for Patients With Hepatic Cirrhosis December 1, 2023 March 30, 2027
NCT06050993 Not yet recruiting Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis October 15, 2023 April 15, 2024
NCT05515861 Not yet recruiting N/A Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices September 2022 June 2024
NCT06069947 Not yet recruiting N/A SALT for Liver Cirrhosis With HCC October 20, 2023 June 30, 2027
NCT05205954 Not yet recruiting N/A HepHospital: A Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease March 1, 2024 December 30, 2025
NCT05490147 Not yet recruiting N/A Effect of Low Tidal Ventilation on Intraoperative Bleeding in Laparoscopic Major Hepatectomy August 8, 2022 August 8, 2023
NCT04806581 Not yet recruiting Phase 1 Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis April 20, 2021 March 31, 2025
NCT06114355 Not yet recruiting Comparison of Pre-operative EUS Guided and Intra-operative Direct Portal Vein Pressure Measurement in Pretransplant Cirrhotics December 1, 2023 December 1, 2024
NCT06279845 Not yet recruiting A Clinical Cohort Study on the Pathogen Spectrum of Hepatic Virus-caused Cirrhosis Complicated With Infection March 2024 November 2026
NCT06041932 Not yet recruiting N/A Pentoxifylline Plus Carvedilol vs Carvedilol Monotherapy in Preventing New Decompensation in Stable Cirrhotic Patients With Prior Decompensation November 1, 2023 August 31, 2024
NCT06121908 Not yet recruiting Role of Blood Lactate Level in Prediction of Outcome of Cirrhotic Patients at The Intensive Care Unit November 15, 2023 November 2024
NCT06031740 Not yet recruiting N/A A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids September 7, 2023 August 31, 2024
NCT06026267 Not yet recruiting N/A Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis September 5, 2023 December 31, 2024
NCT03130127 Not yet recruiting N/A Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis July 1, 2024 December 1, 2025
NCT06022237 Not yet recruiting N/A Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy. September 1, 2023 August 30, 2024
NCT06461208 Recruiting Phase 3 A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis June 21, 2023 April 30, 2027
NCT01298271 Recruiting Phase 4 A Randomized Trial of GVS Alone vs. Propranolol April 2010 December 31, 2025
NCT02038517 Recruiting Cirrhosis, Effects of TRAnsplantation and Diabetes June 2013 December 2026
NCT02423395 Recruiting Phase 3 Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis January 2015 December 2028
NCT02485184 Recruiting N/A TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis July 9, 2017 December 31, 2024
NCT03005444 Recruiting N/A Anticoagulation for Advanced Cirrhotic Patients After TIPS June 14, 2017 December 31, 2024
NCT03080129 Recruiting N/A Microbiome and Sarcopenia in Patients With Liver Cirrhosis April 11, 2017 December 2026
NCT03267615 Recruiting VICIS - Vienna Cirrhosis Study February 1, 2017 December 31, 2027
NCT03584204 Recruiting Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome January 1, 2018 August 31, 2026
NCT03933891 Recruiting Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS August 28, 2018 May 30, 2025
NCT03996135 Recruiting N/A Evaluation of Accuvein in Cirrhotics Patients June 15, 2020 June 30, 2023
NCT04088058 Recruiting Phase 2 A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis November 16, 2019 April 19, 2025
NCT04414956 Recruiting N/A Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma July 1, 2016 February 28, 2026
NCT04421924 Recruiting N/A Periinterventional Coagulation Management of Patients Undergoing a TIPS May 27, 2020 May 2025
NCT04448028 Recruiting Phase 4 Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial April 22, 2021 March 2025
NCT04578301 Recruiting Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease September 22, 2020 December 31, 2026
NCT04613921 Recruiting Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs July 8, 2021 December 31, 2026
NCT04639323 Recruiting Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005) December 23, 2020 January 1, 2025
NCT04724148 Recruiting N/A Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension January 1, 2022 November 1, 2024
NCT04863703 Recruiting Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) May 7, 2021 December 31, 2024
NCT04932577 Recruiting Phase 2/Phase 3 Faecal Microbiota Transplantation for Liver Cirrhosis July 1, 2021 May 31, 2027
NCT04975490 Recruiting Characterization and Pathogenesis of ACLF December 1, 2020 December 31, 2025
NCT05021406 Recruiting N/A Extension Study of Carvedilol RCT Study January 8, 2021 October 30, 2024
NCT05061576 Recruiting N/A Instructed Home-based Physical Exercise for Patients With Liver Cirrhosis August 16, 2022 December 31, 2026
NCT05104541 Recruiting N/A Impact of Weight Loss in Cirrhosis With Obesity and MAFLD November 10, 2021 November 9, 2023
NCT05106972 Recruiting N/A Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis December 1, 2021 December 31, 2025
NCT05181826 Recruiting Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer May 21, 2019 December 2025
NCT05185154 Recruiting Natural Course and Prognosis of Hospitalized Patients With Cirrhosis November 1, 2021 October 31, 2025
NCT05199259 Recruiting Multi-analyte Blood Test Clinical Trial March 1, 2022 March 2025
NCT05253287 Recruiting Phase 2/Phase 3 Growth Hormone in Decompensated Liver Cirrhosis February 1, 2022 January 2025
NCT05342350 Recruiting International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy April 15, 2022 July 1, 2032
NCT05360420 Recruiting N/A Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure October 26, 2022 December 31, 2024
NCT05457114 Recruiting Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver Transplantation May 1, 2022 December 31, 2022
NCT05457543 Recruiting Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests June 30, 2022 March 2023
NCT05466669 Recruiting Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis March 9, 2022 February 10, 2025
NCT05502198 Recruiting Relevance of Sarcopenia in Advanced Liver Disease February 1, 2021 June 30, 2030
NCT05516498 Recruiting Phase 2 Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study) October 31, 2022 April 16, 2025
NCT05542615 Recruiting Phase 2 Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA). August 1, 2019 January 1, 2024
NCT05596253 Recruiting Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis October 11, 2022 July 2025
NCT05596760 Recruiting N/A Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers September 11, 2023 July 2027
NCT05641337 Recruiting Phase 3 Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes October 1, 2022 December 30, 2025
NCT05658393 Recruiting N/A Web-based Mobile Health Application for Patients With Liver Cirrhosis (ReLiver-N App) October 1, 2022 October 9, 2023
NCT05667805 Recruiting Phase 4 Coagulation in Cirrhosis January 19, 2023 March 1, 2027
NCT05672589 Recruiting N/A To Compare Relaxed Rotational Thromboelastometry Cut-offs With Standard Cut-offs for Guiding Blood Product Use Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure Patients February 2, 2023 December 31, 2023
NCT05690750 Recruiting Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations. January 19, 2023 April 30, 2023
NCT05699824 Recruiting N/A To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C Cirrhosis July 1, 2023 June 30, 2024
NCT05719480 Recruiting A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer November 20, 2022 December 20, 2025
NCT05741372 Recruiting N/A A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis April 25, 2023 January 27, 2025
NCT05741385 Recruiting N/A A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis April 25, 2023 January 27, 2025
NCT05782556 Recruiting Freiburg TIPS Registry January 1, 2023 June 30, 2034
NCT05807425 Recruiting Phase 2/Phase 3 Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver Cirrhosis March 31, 2023 December 31, 2023
NCT05869591 Recruiting Phase 2 DOAC in Patients With Child A or B Liver Cirrhosis January 18, 2024 May 2025
NCT05899309 Recruiting Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort Study May 23, 2022 September 2024
NCT05939947 Recruiting Phase 1 A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis April 1, 2023 November 30, 2024
NCT05960006 Recruiting A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis July 10, 2023 September 10, 2024
NCT05971108 Recruiting N/A Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC January 8, 2024 July 31, 2030
NCT06084234 Recruiting Phase 4 National Liver Cancer Screening Trial December 26, 2023 December 31, 2034
NCT06092385 Recruiting SASL Swiss Cirrhosis Cohort January 20, 2023 January 2033
NCT06101758 Recruiting N/A Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study October 20, 2023 July 2025
NCT06129617 Recruiting N/A Intermittent ADVOS vs. Hemodialysis in Non-intensive Care Patients With Liver Dysfunction June 1, 2023 June 1, 2026
NCT06144086 Recruiting Phase 2 A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201) May 8, 2024 June 30, 2025
NCT06144437 Recruiting Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLD November 1, 2023 June 30, 2025
NCT06147934 Recruiting Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD November 1, 2023 January 1, 2025
NCT06147947 Recruiting Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD December 1, 2023 January 1, 2025
NCT06150482 Recruiting Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study September 1, 2022 September 1, 2024
NCT06161766 Recruiting Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease March 15, 2024 June 15, 2025
NCT06169592 Recruiting Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation April 22, 2022 September 14, 2024
NCT06206655 Recruiting Diagnosis of Adrenal Insufficiency in Liver Cirrhosis Patients December 1, 2023 August 31, 2024
NCT06256432 Recruiting Phase 2 Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome April 17, 2024 June 2025
NCT06265272 Recruiting Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis December 10, 2023 December 19, 2026
NCT06269484 Recruiting Phase 2 A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK February 15, 2024 January 17, 2025
NCT06312826 Recruiting N/A Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk August 26, 2022 December 2027
NCT06380335 Recruiting Study in Patients With Decompensated Liver Cirrhosis October 10, 2023 November 3, 2026
NCT06392503 Recruiting Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis November 30, 2023 December 31, 2025
NCT01233102 Suspended Phase 1/Phase 2 Mesenchymal Stem Cells Treat Liver Cirrhosis October 2009 December 2019
NCT00913289 Terminated Phase 1 Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells February 2009 April 2010
NCT02311985 Terminated N/A Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial September 2014 December 2016
NCT00857181 Terminated Cytokines and the Risk of Infection in Liver Cirrhosis March 2009 March 2010
NCT01113567 Terminated N/A Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy July 2010 July 26, 2021
NCT00470340 Terminated Phase 3 Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients June 2007 November 2008
NCT03479125 Terminated Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo February 27, 2018 September 30, 2019
NCT00359437 Terminated Phase 3 Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver July 2006 October 2008
NCT00465842 Terminated Protein Biomarker in Hepatocellular Carcinoma June 20, 2006 August 14, 2013
NCT02418039 Terminated N/A High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy March 10, 2017 July 26, 2021
NCT04140591 Terminated Phase 2/Phase 3 Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis December 26, 2016 December 31, 2019
NCT01951209 Terminated N/A Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis November 17, 2016 June 12, 2017
NCT01518595 Terminated Phase 2 Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis October 2011
NCT02798939 Terminated Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients March 1, 2010 February 14, 2017
NCT00763776 Terminated N/A Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector July 2008 September 2010
NCT02439307 Terminated N/A Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial February 28, 2017 July 26, 2021
NCT02448160 Terminated N/A Alfapump-albumin Replacement Therapy January 2016 December 2017
NCT01236339 Terminated N/A Early TIPS for Ascites Study December 2010 March 2013
NCT01379469 Terminated Phase 2 Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency January 2012 February 2017
NCT00337740 Terminated Phase 3 Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
NCT03202498 Terminated N/A Safety and Tolerability of Yaq-001 in Patients With Cirrhosis February 28, 2019 March 26, 2020
NCT02612519 Terminated N/A Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites November 2015 April 30, 2019
NCT01842113 Terminated Phase 4 Quality of Life and Nutritional Improvements in Cirrhotic Patients April 2013
NCT00366795 Terminated Phase 3 Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver August 2006 December 2008
NCT02602210 Terminated Phase 3 Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis January 2015 December 31, 2020
NCT02556138 Terminated N/A Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates September 1, 2015 November 3, 2016
NCT00382278 Terminated Phase 1/Phase 2 Safety Study of Autologous Stem Cell in Liver Cirrhosis November 2005 February 2008
NCT01686880 Terminated Phase 2 Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver September 2012 January 2015
NCT01629095 Terminated Genetic Studies of Non-Alcoholic Fatty Liver Disease April 23, 2013 January 9, 2017
NCT04048876 Terminated Phase 2 Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis August 14, 2019 September 28, 2021
NCT03022630 Terminated N/A Palliative Care for Non-Malignant Diseases (COMPASS Trial) February 6, 2017 June 21, 2018
NCT03059446 Terminated Phase 2 Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis February 14, 2017 January 5, 2021
NCT00811967 Terminated Phase 3 Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED) February 2003 May 2006
NCT06082843 Terminated Phase 2 A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly January 3, 2024 May 30, 2024
NCT01937130 Terminated Phase 2 Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF September 2013 February 2015
NCT01311167 Terminated Phase 3 Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone February 2011 November 2011
NCT00281502 Unknown status Phase 2 The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy December 2005 December 2012
NCT04621812 Unknown status Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year. November 8, 2020 October 10, 2022
NCT04640350 Unknown status Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography December 31, 2020 May 31, 2023
NCT01728688 Unknown status Phase 1/Phase 2 Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis September 2012 September 2015
NCT01724697 Unknown status Phase 1/Phase 2 Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis September 2012 September 2015
NCT01720238 Unknown status Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis March 2012 December 2018
NCT01718587 Unknown status Phase 1/Phase 2 Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients November 2012 July 2014
NCT04727320 Unknown status Early Phase 1 The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis. March 5, 2021 July 30, 2021
NCT01618890 Unknown status Phase 3 Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding September 2012 December 2022
NCT01573923 Unknown status Phase 1/Phase 2 Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis July 2014 October 2015
NCT04794946 Unknown status N/A Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis March 19, 2021 March 19, 2022
NCT01560845 Unknown status Phase 2/Phase 3 ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis June 2010 June 2014
NCT01558895 Unknown status Phase 2/Phase 3 Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites March 2012 April 2013
NCT04812054 Unknown status N/A Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death April 5, 2021 April 2024
NCT04816240 Unknown status N/A Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis. May 15, 2021 March 19, 2022
NCT04819568 Unknown status N/A Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock. June 25, 2021 March 19, 2022
NCT01543646 Unknown status Multiparametric MR for Rapid Imaging Assessment of the Liver March 2011 September 2012
NCT04828512 Unknown status Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated Cirrhosis January 2, 2007 December 30, 2021
NCT01499459 Unknown status N/A Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis June 2008 August 2012
NCT01483248 Unknown status Phase 1/Phase 2 Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis October 2010 October 2015
NCT01433848 Unknown status Prospective Analysis Of Cardiac Function In Cirrhotic Patients By Echocardiography And Its Correlation With Events June 2011
NCT04874428 Unknown status Phase 1 Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis May 19, 2021 December 2021
NCT04890210 Unknown status N/A Initiation of Diet in Esophageal Varices After Ligation (IDEAL) Study May 20, 2021 December 1, 2021
NCT04896723 Unknown status Sexual Dysfunction in Patients With Chronic Liver Disease June 1, 2021 May 31, 2022
NCT04932200 Unknown status The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis June 15, 2021 April 30, 2022
NCT01071746 Unknown status Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF) September 2008 November 2010
NCT04949178 Unknown status Impact of Continuous Renal Replacement Therapy on Systemic Hemodynamics and Lactate Clearance in Critically Ill Cirrhotics With Septic Shock. June 25, 2021 June 30, 2022
NCT04969055 Unknown status Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking Imaging November 1, 2020 July 31, 2022
NCT01423708 Unknown status Phase 2 Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study February 2010 January 2014
NCT01421550 Unknown status Phase 3 Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis January 2011 December 2015
NCT01389115 Unknown status Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation July 2001 September 2016
NCT01380951 Unknown status Phase 4 Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB) May 2011 December 2013
NCT01025622 Unknown status Phase 1 Intrahepatic Reinfusion of CD133+ Stem Cells in Cirrhotic Patients October 2009 June 2012
NCT05036031 Unknown status Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study September 1, 2021 October 31, 2021
NCT05055713 Unknown status N/A A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism September 25, 2020 December 31, 2022
NCT05057572 Unknown status N/A Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices October 1, 2021 August 30, 2023
NCT05060523 Unknown status N/A To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial) September 19, 2021 September 30, 2022
NCT01358123 Unknown status Value of Von Willebrand Factor in Portal Hypertension September 2006 June 2016
NCT01335568 Unknown status Phase 1 Hepatocyte Matrix Implant Study Indonesia April 2011 December 2012
NCT05088811 Unknown status The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma August 21, 2021 September 2022
NCT05094869 Unknown status Prevention of HCC Using Mobile Phone Applications November 15, 2021 December 31, 2023
NCT01002001 Unknown status Sleep Disorders Pre and Post Liver Transplantation October 2009 December 2010
NCT00993941 Unknown status Phase 2 Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein October 2009 April 2011
NCT05120557 Unknown status N/A Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH September 2022 September 2023
NCT00978978 Unknown status N/A Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver Disease October 2009
NCT05187715 Unknown status N/A To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis. February 26, 2022 October 2023
NCT00976287 Unknown status Phase 2 Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis January 2008 June 2010
NCT01298284 Unknown status Phase 4 A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol October 2009 December 2011
NCT05208736 Unknown status A Model Based on Computed Tomography Imaging Parameters to Predict Poor Survival in Patients With Liver Cirrhosis March 1, 2021 March 15, 2023
NCT01282398 Unknown status Phase 4 Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis April 2011 April 2015
NCT00004368 Unknown status Phase 1 Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis May 1990
NCT05302661 Unknown status N/A Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis February 19, 2022 February 19, 2024
NCT01282385 Unknown status Phase 4 Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension April 2011 April 2014
NCT05335213 Unknown status Urinary Tract Infections in Cirrhosis January 5, 2022 April 5, 2024
NCT00332904 Unknown status Phase 4 Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis August 2006 December 2010
NCT05376943 Unknown status Possible Differences in HCC Course Depending on DAA Treatment May 10, 2022 December 2022
NCT05386953 Unknown status Intraoperative Normal Saline Administration and Acute Kidney Injury in Patients Undergoing Liver Transplantation April 1, 2022 December 31, 2022
NCT01224327 Unknown status Phase 1/Phase 2 Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients October 2010 December 2012
NCT05397860 Unknown status N/A Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma Treatment January 6, 2020 August 30, 2023
NCT01223664 Unknown status Phase 2 Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis October 2010 November 2011
NCT01201655 Unknown status Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis January 2010 December 2012
NCT00935454 Unknown status Phase 1 Hepatocyte Matrix Implant Study July 2009 March 2012
NCT00005107 Unknown status Phase 1 Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
NCT01143948 Unknown status Phase 4 Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial January 2011 May 2011
NCT01108380 Unknown status N/A Evaluation of Liver Regeneration With Autologous Peripheral Stem Cells January 2009 December 2011
NCT00849641 Unknown status Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis March 2009 March 2011
NCT02695732 Unknown status Phase 4 The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding December 2015 September 2018
NCT02705742 Unknown status Phase 1/Phase 2 Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis January 2016 December 2017
NCT02710227 Unknown status Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis September 2018 December 2019
NCT02767206 Unknown status Evaluation of Gastroesophageal Varices by Transnasal Endoscopy. March 2016
NCT02692430 Unknown status The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP). April 2016 December 2017
NCT02642874 Unknown status Phase 3 Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients April 1, 2017 December 2020
NCT02642861 Unknown status Phase 3 Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis October 2018 December 2019
NCT02837302 Unknown status Phase 4 Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease November 2012 June 2018
NCT02642484 Unknown status Phase 3 Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis December 2018 December 2022
NCT02853526 Unknown status Phase 3 TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV July 2015 December 2018
NCT02630095 Unknown status Phase 4 The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT December 2015 September 2018
NCT02889094 Unknown status French HIV-HBV Cohort October 2016 September 2018
NCT02923336 Unknown status N/A Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics May 2015 May 2021
NCT02926261 Unknown status Methods for Nutritional Assessment in Cirrhosis December 2016 December 2021
NCT02943889 Unknown status Phase 1/Phase 2 Stem Cell Transplantation in Cirrhotic Patients October 2016 August 2017
NCT02551250 Unknown status Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis September 2015 December 2019
NCT02987712 Unknown status N/A Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive Procedures December 2016 December 2018
NCT02542020 Unknown status Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis June 2015 May 2022
NCT00822991 Unknown status N/A Sonazoid Enhanced Liver Cancer Trial for Early Detection January 2009 December 2019
NCT03092401 Unknown status Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study October 1, 2015 March 31, 2017
NCT03114813 Unknown status Can MRI Evaluate Beta-blocker Response in Portal Hypertension? January 2017 January 2024
NCT03675633 Unknown status Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Liver Cirrhosis May 1, 2021 January 31, 2022
NCT02256514 Unknown status Phase 2 Open Label Trial of Immunotherapy for Advanced Liver Cancer September 2014 December 2019
NCT02239991 Unknown status N/A Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant September 2014 February 2016
NCT03729921 Unknown status N/A Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric Varices November 2018 June 2020
NCT02221570 Unknown status N/A Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis June 2014 November 2014
NCT02178319 Unknown status N/A Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial June 2014 September 2021
NCT02120196 Unknown status Phase 3 Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis January 2014 December 2023
NCT03892681 Unknown status N/A Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma April 2019 December 2022
NCT03957655 Unknown status Early Phase 1 Safety and Efficacy of SHED for Decompensated Liver Cirrhosis December 2, 2019 December 31, 2021
NCT03989973 Unknown status Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis September 1, 2016 September 1, 2023
NCT03995251 Unknown status N/A Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis. July 4, 2019 June 30, 2020
NCT00709085 Unknown status To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC) April 2008 December 2009
NCT04012021 Unknown status N/A EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI May 24, 2019 December 31, 2020
NCT04058613 Unknown status N/A Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites September 10, 2019 August 8, 2021
NCT04076631 Unknown status Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma August 1, 2019 December 2020
NCT00678613 Unknown status Phase 2/Phase 3 Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial July 2007
NCT02023190 Unknown status Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation January 3, 2019 December 2022
NCT02022150 Unknown status Body Composition Analysis in Cirrhotic Undergoing Paracentesis December 2012 December 2021
NCT04184934 Unknown status Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage January 1, 2019 January 30, 2021
NCT04207398 Unknown status N/A TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary Prophylaxis June 1, 2020 December 31, 2022
NCT01971333 Unknown status Dynamic Preload Parameters During Liver Transplantation October 2013 October 2014
NCT01942915 Unknown status Phase 1 Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis January 2012 December 2014
NCT01897051 Unknown status Phase 2/Phase 3 Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients July 2013 June 2017
NCT01894867 Unknown status Phase 4 Magnesium in Liver Cirrhosis August 2013
NCT04399512 Unknown status N/A Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis Patients January 1, 2020 June 2021
NCT04406298 Unknown status N/A Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory Ascites July 4, 2020 May 20, 2021
NCT00540397 Unknown status N/A TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
NCT04433481 Unknown status N/A Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis June 20, 2020 May 31, 2022
NCT04437810 Unknown status N/A To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development July 8, 2020 April 30, 2022
NCT04443049 Unknown status N/A To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. July 10, 2020 June 19, 2022
NCT01081236 Unknown status Intestinal Barrier Function and Liver Cirrhosis May 2010 May 2012
NCT04489108 Unknown status N/A Tranexamic Acid for Acute Upper Gastrointestinal Bleed in Cirrhosis November 5, 2020 April 30, 2022
NCT01877759 Unknown status Phase 1/Phase 2 A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis December 2013 December 2014
NCT01846949 Unknown status Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS) May 2013 October 2022
NCT04533932 Unknown status Endosonographic Shear Wave Elastography for Liver Stiffness September 8, 2020 August 2021
NCT01728727 Unknown status Phase 1/Phase 2 Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis September 2012 September 2015
NCT03530761 Unknown status Korean Cohort Study of AKI & HRS in Cirrhosis August 1, 2017 December 31, 2019
NCT03571711 Unknown status Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis June 28, 2018 January 1, 2021
NCT03580577 Unknown status Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic September 1, 2018 September 1, 2019
NCT01097811 Unknown status N/A Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy June 2008 December 2010
NCT02325622 Unknown status Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous Diabetes December 2013 February 2017
NCT02321579 Unknown status N/A Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities December 2014 July 2017
NCT03623360 Unknown status Functional MRI to Determine Severity of Cirrhosis September 2018 February 2019
NCT03626090 Unknown status Phase 1/Phase 2 Mesenchymal Stem Cell Therapy for Liver Cirrhosis August 18, 2018 October 22, 2021
NCT03673215 Unknown status Early Phase 1 The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment June 28, 2018 December 31, 2020
NCT02311608 Unknown status Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails February 2014 June 2016
NCT03158701 Unknown status Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic Patients June 1, 2017 June 1, 2018
NCT03171727 Unknown status N/A Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction June 1, 2017 December 30, 2019
NCT02508623 Unknown status Phase 3 Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices July 2015 July 2017
NCT03209986 Unknown status N/A Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis November 8, 2017 December 31, 2019
NCT02475928 Unknown status N/A Zinc Supplementation in Cirrhotic Patients April 2015 December 2019
NCT03241823 Unknown status Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs. December 1, 2017 March 2019
NCT02470546 Unknown status Phase 4 Metformin Experience on Minimal Hepatic Encephalopathy March 2015 December 2016
NCT03269786 Unknown status Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment November 1, 2018 November 1, 2019
NCT03322696 Unknown status ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO) October 1, 2017 June 30, 2021
NCT02415348 Unknown status N/A The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers April 2015 August 2016
NCT03391245 Unknown status Vitamin D Level and Risk of Infections in Cirrhotic Patients August 1, 2017 February 15, 2018
NCT02407769 Unknown status N/A Late Evening Supplementation With Branched Chain Amino Acids in Liver Transplantation February 2014 December 2017
NCT03414398 Unknown status Assessing Cirrhosis Quality of Care While Accounting for Cost December 26, 2017 July 1, 2021
NCT02405416 Unknown status N/A Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving the Portal Triad Clamping March 2015 June 2017
NCT02398357 Unknown status Phase 4 The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis March 2015 December 2017
NCT02385422 Unknown status Phase 4 The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding March 2015 November 2017
NCT02343653 Unknown status N/A The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver Cirrhosis January 2015 July 2018
NCT03470389 Unknown status N/A Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM) March 20, 2018 September 2020
NCT03482076 Unknown status N/A Iron Deficiency Anemia in Childern With Liver Cirrhosis March 1, 2019 June 1, 2020
NCT03509194 Unknown status Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver Insufficiency December 17, 2017 December 17, 2020
NCT02526303 Withdrawn N/A Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
NCT02048969 Withdrawn Phase 1/Phase 2 Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS June 2014 October 2017
NCT03161106 Withdrawn N/A To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis. May 15, 2017 October 1, 2018
NCT01501240 Withdrawn Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver January 2012 August 2013
NCT00748904 Withdrawn Phase 4 Rifaximin Versus Lactulose in Renal Failure June 2008 July 2009
NCT02899325 Withdrawn FDGal PET/CT to Detect Hepatocellular Carcinoma October 2019 October 2021
NCT03202524 Withdrawn Phase 4 Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis December 2017 July 2018
NCT00381017 Withdrawn Phase 3 Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) September 2006
NCT04109144 Withdrawn Phase 2 Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis November 11, 2019 July 2023
NCT01091233 Withdrawn The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study March 2010 December 2012
Disase is a (Disease Ontology)
DOID:409
Cross Reference ID (Disease Ontology)
EFO:0001422
Cross Reference ID (Disease Ontology)
ICD10CM:K74.60
Cross Reference ID (Disease Ontology)
MESH:D008103
Cross Reference ID (Disease Ontology)
NCI:C2951
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:19943007
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0023890
Exact Synonym (Disease Ontology)
Cirrhosis
Exact Synonym (Disease Ontology)
cirrhosis of liver
MeSH unique ID (MeSH (Medical Subject Headings))
D008103